Bristol Myers Squibb announced early participation results and amendment of tender offers for its outstanding notes.
The company adjusted the maximum aggregate purchase prices of Pool 1 and Pool 2 Notes.
Details of the tender offers and the acceptance of tendered notes were provided in the filing.
Amendment of Purchase Prices
The maximum aggregate purchase prices of Pool 1 and Pool 2 Notes were adjusted.
Acceptance of Tendered Notes
Bristol Myers Squibb will accept all validly tendered notes in accordance with the announced amendments.
Obligations and Conditions
The company's acceptance of tendered notes is subject to the terms and conditions outlined in the Offer to Purchase.
- The early participation results indicate investor interest in Bristol Myers Squibb's tender offers.
- Adjustments to the purchase prices reflect strategic decisions to manage the tender process effectively.
Bristol Myers Squibb's early participation results indicate a successful tender offer process with amendments to maximize acceptance of validly tendered notes. The company's strategic adjustments demonstrate commitment to efficient capital management and investor engagement.